Glaukos (GKOS) Cost of Revenue (2014 - 2026)
Glaukos' (GKOS) quarterly Cost of Revenue came in at $33.3 million in Q1 2026, up 37.11% year-on-year from $24.3 million in Q1 2025, and up 4.94% on a QoQ basis from $31.8 million in Q4 2025.
Glaukos (GKOS) Cost of Revenue (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Cost of Revenue data on file, last reported at $33.3 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 37.11% year-over-year to $33.3 million in Q1 2026; TTM through Mar 2026 was $120.8 million, a 23.2% increase from a year earlier, with the FY2025 full-year figure at $111.8 million, up 18.92% from the prior year.
- Cost of Revenue for Q1 2026 stood at $33.3 million, up from $31.8 million in the prior quarter.
- Over the last five years, Cost of Revenue for GKOS reached as high as $33.3 million in Q1 2026 and fell as low as $16.9 million in Q3 2022.
- Historically, Cost of Revenue has averaged $22.6 million across 5 years, with a median of $20.3 million in 2024.
- Across the five-year window, Cost of Revenue gained 0.42% in 2022 and jumped 51.58% in 2024, its largest moves.
- Year by year, Cost of Revenue stood at $17.2 million in 2022, then gained by 9.69% to $18.9 million in 2023, then jumped by 51.58% to $28.6 million in 2024, then rose by 10.95% to $31.8 million in 2025, then grew by 4.94% to $33.3 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $33.3 million in Q1 2026, $31.8 million in Q4 2025, and $28.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 33.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.34 Mn |
| Mar 31, 2026 | 33.34 Mn |
| Dec 31, 2025 | 31.77 Mn |
| Dec 31, 2025 | 31.77 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Dec 31, 2024 | 28.64 Mn |
| Dec 31, 2024 | 28.64 Mn |
| Sep 30, 2024 | 22.58 Mn |
| Sep 30, 2024 | 22.58 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Mar 31, 2024 | 20.26 Mn |
| Mar 31, 2024 | 20.26 Mn |
| Dec 31, 2023 | 18.89 Mn |
| Dec 31, 2023 | 18.89 Mn |